News

Based on preclinical study data, Sepracor believes that SEP-225289 has the potential to be a leading drug candidate in the newly emerging field of triple reuptake inhibitors (TUIs).

Ulcerative colitis is one of multiple indications including rheumatoid arthritis, psoriasis, and Crohn’s disease, in which Remicade is either approved or in late stage development. A pooled analysis

The results published in The New England Journal of Medicine were described in the journal as “simply stunning” by Gabriel Hortobagyi of the University of Texas MD Anderson

This expanded indication will allow healthcare practitioners to vaccinate younger children against hepatitis A with Havrix and may help to further reduce the incidence of hepatitis A in

The analysis of the data suggested that the combination of the two drugs was no more effective in treating the disease than the use of Avastin on its

According to Bristol-Myers and Merck, the FDA wishes to address more fully the cardiovascular safety profile of the drug. The agency will therefore need data from ongoing trials,

The partnership says that it “encourages” the study of neural crest stem cells as potential transplantable tissue for the repair of injury such as that sustained during traumatic

The acquisition includes the non-hormone birth control treatment ParaGard, which is approved for continuous use for the prevention of pregnancy for up to 10 years. The treatment was

The company has announced that it will eliminate the positions of senior vice president of clinical development and the vice president of regulatory affairs and compliance. Although, the